```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 700 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
H. RES. 700

Expressing support for the designation of September 2023 as ``National 
                   Prostate Cancer Awareness Month''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 19, 2023

 Mr. Payne (for himself, Mr. Fitzpatrick, Ms. Adams, Ms. Crockett, Mr. 
Jackson of Illinois, Mr. Meeks, Mr. Carter of Louisiana, Mr. Bacon, Mr. 
   Veasey, Mr. Davis of North Carolina, Ms. Clarke of New York, Mr. 
Carson, Ms. Williams of Georgia, Mr. Grijalva, Mr. Hunt, Mr. Johnson of 
Georgia, Mr. Dunn of Florida, Mr. Lieu, Mr. Grothman, Mr. Menendez, Mr. 
    Valadao, Mr. Westerman, Ms. Caraveo, and Mr. Bishop of Georgia) 
submitted the following resolution; which was referred to the Committee 
                         on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION

 
Expressing support for the designation of September 2023 as ``National 
                   Prostate Cancer Awareness Month''.

Whereas more than 3,100,000 men have at some point been diagnosed with prostate 
        cancer and are still alive in the United States;
Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer 
        in their lifetimes and 1 in 41 men in the United States will die from 
        prostate cancer;
Whereas prostate cancer is the most commonly diagnosed nonskin cancer and the 
        second-leading cause of cancer-related deaths among men in the United 
        States;
Whereas the American Cancer Society estimates that, in 2023, 288,300 men will be 
        diagnosed with, and more than 34,700 men will die of, prostate cancer;
Whereas 40 percent of newly diagnosed prostate cancer cases occur in men under 
        the age of 65;
Whereas the odds of developing prostate cancer rise rapidly after age 50;
Whereas African-American men suffer from a prostate cancer incidence rate that 
        is significantly higher than that of White men and have more than double 
        the prostate cancer mortality rate than that of White men;
Whereas having a father or brother with prostate cancer more than doubles the 
        risk of a man developing prostate cancer, with a higher risk for men who 
        have a brother with the disease and the highest risk for men with 
        several affected relatives;
Whereas screening by a digital rectal examination and a prostate-specific 
        antigen blood test can detect the disease at the earlier, more treatable 
        stages, which could increase the chances of survival for more than 5 
        years to nearly 100 percent;
Whereas only 32 percent of men survive more than 5 years if diagnosed with 
        prostate cancer after the cancer has metastasized;
Whereas there are typically no noticeable symptoms of prostate cancer in the 
        early stages, making appropriate screening critical;
Whereas, in fiscal year 2023, Congress appropriated $47,500,000,000 to the 
        National Institutes of Health, including $7,104,159,000 for the National 
        Cancer Institute;
Whereas, in fiscal year 2023, Congress appropriated $110,000,000 for the peer-
        reviewed Prostate Cancer Research Program of the Department of Defense;
Whereas the Department of Veterans Affairs has established 21 Precision Oncology 
        Centers of Excellence in order to deliver precision oncology services to 
        veterans suffering from prostate cancer;
Whereas ongoing research promises further improvements in prostate cancer 
        prevention, early detection, and treatment; and
Whereas educating people in the United States, including health care providers, 
        about prostate cancer and early detection strategies is crucial to 
        saving the lives of men and preserving and protecting families: Now, 
        therefore, be it
    Resolved, That the House of Representatives--
            (1) expresses support for the designation of ``National 
        Prostate Cancer Awareness Month'';
            (2) declares that steps should be taken--
                    (A) to raise awareness about the importance of 
                screening methods for, and treatment of, prostate 
                cancer;
                    (B) to encourage research--
                            (i) to improve screening and treatment for 
                        prostate cancer;
                            (ii) to discover the causes of prostate 
                        cancer; and
                            (iii) to develop a cure for prostate 
                        cancer; and
                    (C) to continue to consider ways to improve access 
                to, and the quality of, health care services for 
                detecting and treating prostate cancer; and
            (3) calls on the people of the United States, interest 
        groups, and affected persons--
                    (A) to promote awareness of prostate cancer;
                    (B) to take an active role in the fight to end the 
                devastating effects of prostate cancer on individuals, 
                families, and the economy; and
                    (C) to observe National Prostate Cancer Awareness 
                Month with appropriate ceremonies and activities.
                                 <all>
```